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Abstract 
Purpose: To document and analyse the decision to withhold or withdraw life-sustaining treatment (LST) in a popula-
tion of very old patients admitted to the ICU.
Methods: This prospective study included intensive care patients aged ≥ 80 years in 309 ICUs from 21 European 
countries with 30-day mortality follow-up.
Results: LST limitation was identified in 1356/5021 (27.2%) of patients: 15% had a withholding decision and 12.2% a 
withdrawal decision (including those with a previous withholding decision). Patients with LST limitation were older, 
more frail, more severely ill and less frequently electively admitted. Patients with withdrawal of LST were more fre-
quently male and had a longer ICU length of stay. The ICU and 30-day mortality were, respectively, 29.1 and 53.1% in 
the withholding group and 82.2% and 93.1% in the withdrawal group. LST was less frequently limited in eastern and 
southern European countries than in northern Europe. The patient-independent factors associated with LST limita-
tion were: acute ICU admission (OR 5.77, 95% CI 4.32–7.7), Clinical Frailty Scale (CFS) score (OR 2.08, 95% CI 1.78–2.42), 
increased age (each 5 years of increase in age had a OR of 1.22 (95% CI 1.12–1.34) and SOFA score [OR of 1.07 (95% 
CI 1.05–1.09 per point)]. The frequency of LST limitation was higher in countries with high GDP and was lower in 
religious countries.
Conclusions: The most important patient variables associated with the instigation of LST limitation were acute 
admission, frailty, age, admission SOFA score and country.
Trial registration: ClinicalTrials.gov (ID: NTC03134807).
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Life expectancy in many countries is steadily increasing. 
As a result, patients admitted to hospital and ultimately 
to the ICU will be older. At present, > 10% of the patients 
admitted to the ICU are ≥ 80 years old [1]. The propor-
tion of older adults is estimated to increase to 30% by 
2050, with a huge impact on total hospital expenditures 
[2]. As a consequence, many ICUs across the globe must 
adapt their policies to these increased demands. Some 
estimate that the need for ICU beds will increase by 50% 
owing to these developments [3]. However, once an older 
adult has been admitted to the ICU for an acute medical 
reason, his/her risk of dying within 30  days is high. For 
frail patients the 30-day mortality is 40.7% [4].
As a result, ICU physicians are increasingly faced with 
difficult decisions on continuation of life sustaining treat-
ment (LST) in older adults. In these situations, decisions 
are being made to withhold LST if patients deteriorate or 
even to withdraw already instigated LST if the short-term 
prognosis is poor. Differences in ethics, religion, culture 
and predictive capacity add to the difficulty of formu-
lating a consistent approach to treatment limitation in 
critical illness. Previous publications have highlighted the 
huge variation in admission policies for older adults in 
Europe [1, 5, 6]. At present, there is a strong consensus 
that age should not be considered as a sole decision-mak-
ing criterion [7–9]. Older adults (like any other patients) 
should be admitted to the ICU only with a predefined, 
reasonable goal of care. Finally, considering their inherent 
frailty, all older adults should undergo systematic reas-
sessment a few days after ICU admission to evaluate the 
appropriateness of their level of care. This concept of an 
“ICU trial” is attractive and has been proposed for cancer 
patients requiring mechanical ventilation [11]. However, 
this should be well organised, explicit, and shared with 
all ICU staff and the patients’ relatives. In most cases, 
important information is lacking when deciding to admit 
an older patient in ICU: no living will, incomplete infor-
mation, and no clarity concerning life expectancy.
Differences in admission policies and health care sys-
tems, together with insufficient information from the 
patients or their relatives (i.e. advanced directives), result 
in huge variability in end-of-life (EOL) care in the ICU 
[12]. In addition, there is considerable variation in the 
proportion of deaths that occur after a decision to limit 
life support and this cannot be explained solely by patient 
characteristics [13, 14] or patients’ preferences [15]. In 
the present study we aim to examine the incidence and 
determinants of LST limitation decisions (withholding 
and withdrawal) in patients older than 80 years admitted 
to ICUs in European countries.
Methods
Study design and setting
The methods and patients have been described in a pre-
vious publication [4]. Briefly, VIP1 is a prospective Euro-
pean multicentre study. Each participating ICU could 
choose to include either consecutive patients through-
out a 3-month period or the first 20 consecutive patients 
within this period. Individual ICUs started data collec-
tion between October 2016 and February 2017, depend-
ing on the speed of local ethics committee approval. A 
website was set up to facilitate sharing of information 
about the study and to allow data entry using an elec-
tronic case report form (CRF). The study was registered 
on ClinicalTrials.gov (ID: NTC03134807).
Participants
All patients aged 80 years or older admitted to the par-
ticipating ICUs were eligible. Patients were followed until 
death or for 30 days after ICU admission.
Variables
The study collected a consistent set of data: age, gender, 
reason for ICU admission from a predefined list of 12 
categories, length of stay (LOS) prior to ICU admission, 
Clinical Frailty Scale (CFS) score [16], admission SOFA 
score [17], any period of non-invasive or invasive ven-
tilation with endotracheal intubation or tracheostomy 
during the ICU stay, use of vasoactive drugs, and renal 
replacement therapy. Severity scores such as SAPS2 were 
optional. ICU outcome (death or survival) and survival at 
day 30 after ICU discharge were collected for all included 
patients. All decisions to withhold and/or withdraw ther-
apy were at the discretion of the treating physician(s) but 
were documented according to international recommen-
dations [18]. However, we did not collect information on 
the timing of such a decision relative to ICU admission 
and/or commencement of organ support.
The CRF and database ran on a secure server at Aarhus 
University, Denmark.
Take‑home message 
Among 5021 very old (≥ 80 years) patients admitted to 309 ICUs in 
21 European countries, the most important patient variables associ-
ated with the instigation of life-sustaining treatment (LST) limitation 
were acute admission, frailty, age and SOFA score. The frequency 
of LST limitation was higher in countries with high GDP and lower 
where more inhabitants considered their religion’s deity very impor-
tant. For patients with only a withholding decision, ICU and 30-day 
mortality were respectively 29.1 and 53.1%.
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Country’s characteristics
Gross domestic product (GDP) and health expenditure 
from individual countries were extracted from EURO-
STAT (http://ec.europ a.eu/euros tat/stati stics -expla ined/
index .php/Healt hcare _expen ditur e_stati stics ). Propor-
tions of elderly patients per country were extracted from 
Health at a Glance 2013: OECD Indicators. Numbers 
of ICU beds per inhabitants were extracted from data 
derived from Rhodes et al. [37].
Data on religious beliefs were extracted from the Euro-
pean Values Study (http://www.europ eanva luess tudy.
eu/).
Bias and study size
The participating ICUs included consecutive patients, 
and decisions to withhold or withdraw LST were docu-
mented. The relationship with 30-day outcome was 
assessed retrospectively after closure of the database. No 
formal sample-size calculation was performed for this 
observational study.
Statistical analysis
Baseline patient characteristics, treatment and outcomes 
were compared among three LST groups: (1) no limita-
tions, (2) withholding alone and (3) withdrawal, whether 
or not preceded by a withholding decision. Continuous 
variables were compared among the groups using the 
Mann–Whitney U test, categorical variables using the 
Chi squared test. Normally distributed continuous data 
were described as medians with 25th to 75th percentiles 
(interquartile range, IQR). Associations between vari-
ables and treatment limitation—i.e. withholding or with-
drawal of LST—were estimated using a logistic regression 
model. To account for the clustering of patients within 
countries, a multilevel logistic regression model was 
used. Two models were built to estimate (a) the effect of 
patient characteristics on treatment limitation and (b) 
the effect of patient and country characteristics on treat-
ment limitation. In order to quantify the country effect, 
we used intraclass coefficient correlation (ICC) and 
median odds ratio (MOR). The ICC represents the pro-
portion of the total observed individual variation in the 
outcome (treatment limitation, i.e. withholding or with-
drawal) that is attributable to between-country variation. 
The higher this proportion, the higher is the general con-
textual effect. If one were to repeatedly sample at ran-
dom two subjects with the same covariates from different 
countries, then the MOR is the ratio between the subject 
at higher risk of the outcome and the subject at the lower 
risk of the outcome (differences in risk are entirely quan-
tified by the country-specific random effects).
Standardized treatment limitation ratios were esti-
mated for each country, defined as the ratio of the 
observed number of treatment limitations in a country 
and the sum of the predicted individual probabilities of 
treatment limitation (estimated from model 1) in the 
same country. The 95% confidence intervals of the ratios 
were estimated using Byar’s approximation.
Associations between variables and survival at 30 days 
after ICU admission were estimated using a Cox pro-
portional hazard regression model. All patients were 
censored at 30 days. Adjusted survival curves were pro-
duced using inverse probability weighting. The weights 
were estimated using frailty, age, gender, type of admis-
sion and SOFA score. Mid-point imputations were used 
for patients discharged from ICU and dead at day 30. A p 
value less than 0.05 was considered to show a statistically 
significant difference.
All analyses were performed with R software, version 
3.2.2 (R Foundation for Statistical Computing).
Ethics
Institutional research ethics board approval was obtained 
from each study site. No specific funding was received, 
but the study was endorsed by ESICM.
Results
In total, 309 ICUs from 21 European countries partici-
pated and included 5132 patients. Follow-up at 30  days 
was completed in 98% (5021/5132) of the patients. The 
median recruited number of patients per country was 
114 and the median number of patients per ICU was 
16. The median age of all patients was 84  years (IQR 
81–86); 52.1% were male. See Table 1 for more baseline 
characteristics.
Patients with no LST limitation accounted for 
3656/5021 (72.8%) patients with only withholding com-
prised 15.0% and patients with withdrawal (including 
those with previous withholding) made up 12.2% of the 
total. Patients with LST limitation were older, more frail, 
more severely ill and less frequently electively admitted 
(Table  1). Patients with withdrawal of LST were more 
frequently male and had a longer ICU LOS. The propor-
tion of LST limitations varied according to diagnostic 
category (ESM3), with a very low frequency for patients 
admitted after elective surgery. Among the non-survivors 
at day 30, 24.3% had a withholding and 34.6% had a with-
drawing LST decision (ESM5). The ICU and 30-day mor-
tality were respectively 29.1 and 53.1% in the withholding 
group and 82.2 and 93.1% in the withdrawal group. The 
unadjusted and adjusted survival curves are depicted in 
Fig. 1.
Provision of organ support also differed according to 
LST decision, with more instances of organ supports in 
the withdrawal group (Table 2).
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LST limitation was less frequent in eastern and south-
ern European countries than in other parts of Europe 
(ESM6). The ICUs located in northern Europe had higher 
rates of LST limitation (up to 45.2%).
Country was found to have a significant effect on the 
decision whether or not to limit LST. The multivariate 
analysis identified independent factors for LST limitation 
decision (Table  3). The most important patient factors 
associated with LST limitation were: acute ICU admis-
sion, CFS score, higher age and admission SOFA score. 
A sensitivity analysis focusing only on urgent admission, 
thus excluding scheduled surgery, found similar results. 
Among the different country characteristics (ESM1) and 
patient characteristics (ESM2), high GDP was associ-
ated with a higher rate of LST limitation, while religios-
ity, defined as the proportion of inhabitants agreeing with 
the statement “God is important”, was associated with 
low rates of LST limitation (Table 3) (Fig. 2). The num-
ber of ICU beds and the age distribution of the popula-
tion had no impact on LST limitation. 
The ICC was 0.14 (empty model), 0.23 (model with 
individual patient characteristics) and 0.08 (model with 
individual patient and country level characteristics). In 
this last model, 8% of the total variation in patients’ treat-
ment limitation is due to country.
The MOR was 2.06 (empty model), 2.57 (model with 
individual patient characteristics) and 1.66 (model with 
individual patient and country level characteristics). 
When comparing two patients with the same frailty level, 
age, gender, SOFA score and type of admission from ran-
domly selected countries, the MOR for the patient from 
the country with the higher risk of treatment limitation 
relative to the patient from the country with the lower 
risk of treatment limitation was 1.66. Thus, in half such 
comparisons, the odds of treatment limitation would be 
less than 1.66 for a patient in the country of higher risk 
relative to an “identical” patient in the country of lower 
risk.
Among patients with withdrawal, invasive mechani-
cal ventilation was highly associated with LST limitation 
decisions (ESM6).
Discussion
Our prospective European study included 5021 patients 
aged 80 years or older. Limitation of LST was instigated 
in 27.2% of these patients. Such limitations were associ-
ated with 30-day mortality of 54.8% in the withholding 
group and 94.2% in the withdrawal group. In this very 
old patient population, several factors other than chrono-
logical age are associated with limitations in LST, such as 
country, urgent admission, frailty and severity of illness 
(SOFA score).
Our findings are potentially important for policy mak-
ers. There was considerable geographical variation in 
preparedness to instigate limitations in LST in older 
adult patients. Using the MOR, we have shown that 
country effects (i.e. ‘culture’) are as important as, or in 
some instances more important than, patient characteris-
tics in terms of the association with decisions to withhold 
or withdraw treatment. An advantage to use of the MOR 
for quantifying the contextual effect is that the MOR is 
on the same scale as that used for estimating measures 
of association when quantifying the effect of subject-level 
(and country-level) covariates on the odds of the out-
come. Thus, one can compare the magnitude of the MOR 
with that of the association between characteristics of the 
subject and the outcome. In examining the odds ratios for 
the model including patient and country characteristics, 
we observed that only two of the six patient characteris-
tics had an odds ratio above 1.66. Thus, the magnitude of 
the effect of clustering (the contextual effect) was higher 
than that of four of the six patient characteristics.
High GDP was associated with higher standard-
ized treatment limitation ratio, while religiosity had the 
opposite effect. This may seem paradoxical, with more 
resources used in countries with lower GDP. From an 
ethical point of view, countries with low GDP potentially 
jeopardize the allocation of resources by postponing (or 
not formalizing) EOL decision making.
Such differences have been noted previously. For 
example, there is lower prevalence of withdrawal of life 
support in Asia than in the USA or in Europe [15, 19]. 
Regional variations have also been reported in the UK 
[20]. These studies suggest that although some variability 
is driven by ICU bed availability, much of the variability 
is driven by the views of individual physicians (culture, 
religion, profile) [21]. This indirectly indicates potential 
violation of the patients’ autonomy (besides inappropri-
ate allocation of resources) and suggests physician- or 
culture-centred care instead of patient-centred care. 
In northern European countries intensivists are appar-
ently more willing to withhold or withdraw LST than in 
eastern and southern European countries. In our study, 
this difference was even more striking for decisions to 
withdraw treatment: 5.5% in eastern Europe vs 17.7% in 
northern Europe. Religion may play a part: the European 
ETHICUS study reported that withholding occurred 
more often than withdrawal if the physician was Jewish 
(81%), Greek Orthodox (78%) or Moslem (63%) [22].
The rate of LST limitation in our study is higher than 
previously reported in the general ICU population. For 
example, LST was limited in 11.0% of patients in France 
[23] and 9.8% in Europe [22]. Several factors may explain 
these differences: a much younger population (the 
median age was 57 and 66, respectively, in the French and 
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European studies); less severely ill patients (lower SAPS 
II scores, lower overall mortality); or the time when the 
study was conducted, with changes in the perceptions of 
society in general and ICU physicians in particular as the 
population ages.
Several studies have documented higher rates of treat-
ment limitation in aged patients compared with their 
younger counterparts [18, 24–26]. In the SUPPORT 
study, older age was associated with higher rates of with-
holding ventilator support and dialysis in adjusted analy-
ses [24, 25]. In a study by Hakim et  al. in the USA, the 
rate of do-not-resuscitate orders increased with age (from 
21% in patients < 54  years to 55% in patients > 84  years) 
[26]. In a study by Hoel et  al. in Norway, medical and 
unscheduled surgical patients with LST limitation were 
older [27]. Other factors besides age have been associ-
ated with increased odds of decisions to forgo LST in US 
ICUs: female sex, white race, poor baseline functional 
status [13] and the treatments given to such patients [24].
In our study, the decision to limit LST was associated 
with increased 30-day mortality (54.8% in the withhold-
ing group and 94.2% in the withdrawal group). The same 
result was found in a recent multicentre observational 
study in France, in which withdrawing or withholding 
Table 1 Patient and ICU stay characteristics according to LST limitation
All No treatment limitation Withholding alone Withdrawing +/− with-
holding
p value
N 5021 3656 753 612
% 100 72.8 15.0 12.2
Age
 Median (range) (IQR) 84 (range 80–102) (IQR: 
81–86)
83 (range 80–102) (IQR 
81–86)
85 (range 80–99) (IQR 
82–87)




 Median (range) (IQR) 4 (range 1–9) (IQR: 3–6) 4 (range 1–9) (IQR 3–5) 5 (range 1–9) (IQR 4–6) 5 (range 1–9) (IQR 3–6) < 0.0001
Hospital length of stay prior ICU admission (days)
Median (range) (IQR) 1 (range 0–168) (IQR: 0–3) 1 (range 0–168) (IQR 0–3) 1 (range 0–151) (IQR 0–3) 0 (range 0–108) (IQR 0–3) 0.0016
SOFA score
 Median (range) (IQR) 7 (range 0–24) (IQR: 4–10) 6 (range 0–24) (IQR 3–9) 7 (range 0–22) (IQR 4–10) 10 (range 0–20) (IQR 7–13) < 0.0001
ICU length of stay (days)
 Median (range) (IQR) 2.33 (range 0–145.58) (IQR: 
1–5.92)
2.29 (range 0–145.58) (IQR 
1–5.66)
2.12 (range 0–125.38) (IQR 
0.92–6)




 Female 2404 (47.9%) 1737 (47.5%) 395 (52.5%) 272 (44.4%) 0.009
 Male 2617 (52.1%) 1919 (52.5%) 358 (47.5%) 340 (55.6%)
Main reason for ICU 
admission
 Missing: 114/ available: 
4907
Missing: 97/ available: 
3559
Missing: 12/available: 741 Missing: 5/ available: 607
 Resp failure 965 (19.7%) 627 (17.6%) 207 (27.9%) 131 (21.6%) < 0.0001
 Circ failure 569 (11.6%) 372 (10.5%) 96 (13%) 101 (16.6%)
 Resp + Circ fail 484 (9.9%) 300 (8.4%) 84 (11.3%) 100 (16.5%)
 Sepsis 502 (10.2%) 315 (8.9%) 111 (15%) 76 (12.5%)
 Multi trauma without 
head injury
63 (1.3%) 43 (1.2%) 9 (1.2%) 11 (1.8%)
 Multi trauma with head 
injury
66 (1.3%) 44 (1.2%) 5 (0.7%) 17 (2.8%)
 Isolated head injury 124 (2.5%) 78 (2.2%) 23 (3.1%) 23 (3.8%)
 Post elective surgery 906 (18.5%) 853 (24%) 38 (5.1%) 15 (2.5%)
 Intoxication 14 (0.3%) 12 (0.3%) 2 (0.3%) 0 (0%)
 Non trauma CNS causes 315 (6.4%) 196 (5.5%) 56 (7.6%) 63 (10.4%)
 Emergency surgery 403 (8.2%) 327 (9.2%) 45 (6.1%) 31 (5.1%)
 Other 496 (10.1%) 392 (11%) 65 (8.8%) 39 (6.4%)
Type of ICU admission
 Elective 906 (18%) 853 (23.3%) 38 (5%) 15 (2.5%) < 0.0001
 Acute 4115 (82%) 2803 (76.7%) 715 (95%) 597 (97.5%)
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care accounted for half of all deaths [28]. In Italy, with-
drawal or withholding preceded 62% of deaths [29]. In 
our study, among the elderly patients dead at day 30, 
41.1% had no LST decision, 24.3% withholding and 34.6% 
withdrawal. However, it should be emphasised that a LST 
limitation decision is not equal to an EOL decision. In 
fact, among the elderly patients with a decision to with-
hold care, the ICU mortality and 30-day mortality were 
only 29.1 and 53.1%, respectively. For patients in whom 
LST was withdrawn, ICU mortality and 30-day mortal-
ity were 82 and 94.2%. Clearly, not all LST limitations are 
EOL decisions, since the mortality rate is low for patients 
Fig. 1 Survival curves according to LST limitation: a unadjusted; b adjusted
Table 2 Treatments, frailty level and outcomes
All No treatment limitation Withholding alone Withdrawing +/− withholding p value
5021 3656 753 612
Non invasive mechanical ventilation
 No 3872 (77.1%) 2910 (79.6%) 509 (67.6%) 453 (74%) < 0.0001
 Yes 1149 (22.9%) 746 (20.4%) 244 (32.4%) 159 (26%)
Invasive mechanical ventilation
 No 2501 (49.8%) 1892 (51.8%) 460 (61.1%) 149 (24.3%) < 0.0001
 Yes 2520 (50.2%) 1764 (48.2%) 293 (38.9%) 463 (75.7%)
Vasoactive drugs
 No 2408 (48%) 1894 (51.8%) 360 (47.8%) 154 (25.2%) < 0.0001
 Yes 2613 (52%) 1762 (48.2%) 393 (52.2%) 458 (74.8%)
Renal replacement therapy
 No 4559 (90.8%) 3355 (91.8%) 682 (90.6%) 522 (85.3%) < 0.0001
 Yes 462 (9.2%) 301 (8.2%) 71 (9.4%) 90 (14.7%)
Frailty level
 Fit 1893 (37.7%) 1545 (42.3%) 161 (21.4%) 187 (30.6%) < 0.0001
 Vulnerable 972 (19.4%) 726 (19.9%) 140 (18.6%) 106 (17.3%)
 Frail 2156 (42.9%) 1385 (37.9%) 452 (60%) 319(52.1%)
Death in ICU
 No 3911 (77.9%) 3268 (89.4%) 534 (70.9%) 109 (17.8%) < 0.0001
 Yes 1110(22.1%) 388 (10.6%) 219 (29.1%) 503 (82.2%)
Death at day 30
 No 3373 (67.2%) 2978 (81.5%) 353 (46.9%) 42 (6.9%) < 0.0001
 Yes 1648 (32.8%) 678 (18.5%) 400 (53.1%) 570(93.1%)
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with only withholding of treatment and not 100% at 
30 days for patients with withdrawal of LST. Apparently, 
LST limitation is proposed when such LST is considered 
disproportionate to the patient’s chances of survival with 
a good quality of life [27, 30]. The impact of LST limi-
tation on mortality is greatest in the first week of ICU 
Table 3 Multilevel logistic regression for withholding or withdrawing vs no LST limitation (level 1 = patient/level 
2 = country)
Empty model Patients characteristics Patients and countries charac-
teristics
OR (95% CI) p value OR (95% CI) p value
Frailty 4 vs 1–3 1.59 (1.3–1.95) < 0.0001 1.59 (1.3–1.95) < 0.0001
Frailty 5–9 vs 1–3 2.33 (1.98–2.75) < 0.0001 2.33 (1.98–2.74) < 0.0001
Age (5 years increase) 1.23 (1.11–1.35) < 0.0001 1.22 (1.11–1.35) < 0.0001
Male vs female patient 1.02 (0.89–1.18) 0.754 1.03 (0.89–1.18) 0.7305
Acute vs elective admission 5.61 (4.13–7.62) < 0.0001 5.59 (4.12–7.59) < 0.0001
Sofa score (one point increase) 1.12 (1.1–1.14) < 0.0001 1.12 (1.1–1.14) < 0.0001
GDP per capita (one point increase) 1 (1–1) 0.01976
Religiosity (one point increase) 0.96 (0.94–0.99) 0.00498
Country effect Point estimate Point estimate Point estimate
MOR 2.06 2.57 1.66






























































Fig. 2 Standardized treatment limitation ratio. The range lines are 95% confidence intervals. a According to the volume index of GDP per capita; b 
according to religiosity, defined as the proportion of the population considering God as very important
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treatment [31], depending on what kind of treatment is 
withdrawn and the number of organs failing at the time 
of LST limitation [31, 32]. We found that the impact of 
LST limitation on survival was discernible until 2 weeks 
after ICU admission (Fig. 1).
In our study, the ICU LOS of patients with LST with-
drawal was a little longer than the other patients but was 
still below 3  days, suggesting an early decision to limit 
LST. In a study from Australia and New Zealand, the 
LOS of older adults was 3.9  days in non-survivors and 
2.5 days in survivors, suggesting that EOL decisions were 
made later in patients older than 80  years [33]. On the 
other hand, data from Scandinavia show shorter LOS for 
non-survivors than survivors in the ICU, particularly for 
older patients [34].
Our study has several strengths: the focus on patients 
older than 80  years, the large number of participating 
ICUs from 21 European countries, the separate docu-
mentation of withholding and/or withdrawal of LST and 
the 30-day follow-up. However, it also has limitations. 
We have no documentation of the timing of the LST 
limitation decision, which could bias the results; patient 
inclusion was mostly during the winter, which may have 
contributed to the high rate of LST limitation; and the 
participating ICUs cannot necessarily be considered 
as representative of their countries. In order to combat 
these weaknesses, we grouped countries into five Euro-
pean regions; we did not document any possible influ-
ence of advance directives or patients’ and/or relatives’ 
preferences in the decision; and included no health eco-
nomic data or bed access/pressure data that could help to 
develop a resource-based argument for deciding on LST 
limitation.
In the older adult population, LST limitation occurs 
frequently. The best criteria for the appropriateness of 
such decision include post-discharge functional capacity, 
mortality and quality of life [35]. A dialogue with fam-
ily members (or care givers) about the possibilities and 
potential outcomes should take place within 72  h of a 
patient being admitted to the ICU [10, 21, 36].
Conclusion
Given the limited survival chances of very old patients 
and the cost and scarcity of ICU resources, an active 
policy for limiting life-sustaining therapy should be advo-
cated for patients who are not responding to treatment 
or not willing to continue ICU treatment. This should 
be accompanied by a campaign encouraging patients to 
express their preferences and wishes before they become 
ill. Better definition of which elderly patients will benefit 
from ICU procedures, rather than drawing up exclusion 
criteria, is a challenge for future studies.
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